Na Zhao

Title: Na Zhao: Innovator in Pharmaceutical Chemistry

Introduction

Na Zhao is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have potential applications in cancer treatment and immune response regulation.

Latest Patents

Na Zhao holds a patent for 3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides. This invention encompasses compounds of general formula (I), where R1, R2, R3, R4, R5, and R6 are defined within the patent. The patent details methods for preparing these compounds, intermediate compounds useful for their synthesis, and pharmaceutical compositions that include these compounds. The applications of these compounds are particularly focused on the treatment or prophylaxis of diseases, especially cancer and conditions associated with dysregulated immune responses or aberrant AHR signaling.

Career Highlights

Throughout his career, Na Zhao has worked with prominent organizations in the pharmaceutical industry. He has been associated with Bayer Pharma Aktiengesellschaft and the German Cancer Research Center (Deutsches Krebsforschungszentrum). His work in these institutions has contributed to advancements in cancer research and drug development.

Collaborations

Na Zhao has collaborated with several professionals in his field, including Norbert Schmees and Ilona Gutcher. These collaborations have fostered innovation and the sharing of knowledge in pharmaceutical research.

Conclusion

Na Zhao's contributions to pharmaceutical chemistry, particularly through his patented inventions, highlight his role as an innovator in the field. His work continues to influence the development of treatments for critical health conditions.